[(1R,3S)-3-[3-[[5-(Methoxymethyl)-2-Methylpyrazole-3-Carbonyl]Amino]-1H-Pyrazol-5-Yl]Cyclopentyl]N-Propan-2-Ylcarbamate Monohydrate

2 trials

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

0 Recruiting

2 Completed trials

1 Sponsors

3 Countries

Phase II

Phase I/II

Phase II: 1 Phase I/II: 1

Indications tested

Breast cancer 1 Small cell lung cancer 1 Ovarian cancer 1 Breast cancer metastatic 1

Sponsors using this IMP

All trials

2 total

PHASE 1/2A DOSE ESCALATION, FINDING AND EXPANSION STUDY EVALUATING SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS AND ANTI TUMOR A… Ended

2024-515492-34-00 Phase I/II 1 country Pfizer Inc.
A Phase 1b/2 Study of PF-07220060 in Combination with PF-07104091 Plus Endocrine Therapy in Participants with BC and other Advanced Solid Tu… Ended

2023-509504-15-00 Phase II 3 countries Pfizer Inc.

Showing 1–2 of 2 trials

← All drugs A–Z